Cancel anytime
Privia Health Group Inc (PRVA)PRVA
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: PRVA (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -40.65% | Upturn Advisory Performance 1 | Avg. Invested days: 20 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -40.65% | Avg. Invested days: 20 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.53B USD |
Price to earnings Ratio 191.91 | 1Y Target Price 26.15 |
Dividends yield (FY) - | Basic EPS (TTM) 0.11 |
Volume (30-day avg) 842765 | Beta 0.76 |
52 Weeks Range 15.92 - 24.30 | Updated Date 11/20/2024 |
Company Size Mid-Cap Stock | Market Capitalization 2.53B USD | Price to earnings Ratio 191.91 | 1Y Target Price 26.15 |
Dividends yield (FY) - | Basic EPS (TTM) 0.11 | Volume (30-day avg) 842765 | Beta 0.76 |
52 Weeks Range 15.92 - 24.30 | Updated Date 11/20/2024 |
Earnings Date
Report Date 2024-11-07 | When BeforeMarket |
Estimate 0.05 | Actual 0.03 |
Report Date 2024-11-07 | When BeforeMarket | Estimate 0.05 | Actual 0.03 |
Profitability
Profit Margin 0.75% | Operating Margin (TTM) 1.33% |
Management Effectiveness
Return on Assets (TTM) 0.77% | Return on Equity (TTM) 2.23% |
Revenue by Products
Revenue by Products - Current and Previous Year
Valuation
Trailing PE 191.91 | Forward PE 31.95 |
Enterprise Value 2117408604 | Price to Sales(TTM) 1.48 |
Enterprise Value to Revenue 1.23 | Enterprise Value to EBITDA 103.99 |
Shares Outstanding 120001000 | Shares Floating 98923117 |
Percent Insiders 10.49 | Percent Institutions 102.76 |
Trailing PE 191.91 | Forward PE 31.95 | Enterprise Value 2117408604 | Price to Sales(TTM) 1.48 |
Enterprise Value to Revenue 1.23 | Enterprise Value to EBITDA 103.99 | Shares Outstanding 120001000 | Shares Floating 98923117 |
Percent Insiders 10.49 | Percent Institutions 102.76 |
Analyst Ratings
Rating 4.57 | Target Price 37.09 | Buy 5 |
Strong Buy 14 | Hold 2 | Sell - |
Strong Sell - |
Rating 4.57 | Target Price 37.09 | Buy 5 | Strong Buy 14 |
Hold 2 | Sell - | Strong Sell - |
AI Summarization
Privia Health Group Inc. - Comprehensive Overview
Company Profile
History and Background
Privia Health Group Inc. (NASDAQ: PRVA) was founded in 2010 as a physician organization focused on transforming primary care delivery. The company has grown through acquisitions and partnerships with independent physician groups, becoming a leading player in the value-based care market.
Core Business Areas
Privia operates in two main segments:
- Physician Group Services: This segment provides practice management, billing, IT, and other support services to independent physician groups and hospital systems.
- Population Health Management: This segment offers population health management programs to health plans and employers, focusing on improving care coordination and reducing costs for chronic disease patients.
Privia leverages technology and data analytics to drive efficiency and effectiveness in its services and programs.
Leadership & Corporate Structure
- Dr. Shahram Ahari: Chairman & CEO
- Brad Groussman: Chief Financial Officer
- Dr. John Henderson: Chief Medical Officer
- Doug Morse: Chief Growth Officer
The company has a Board of Directors comprising experienced individuals from healthcare, finance, and technology backgrounds.
Top Products & Market Share
Privia's key offerings include:
- Primary Care Enablement: Practice management, technology, and billing services for independent physician groups.
- Chronic Disease Management Programs: Care coordination and cost management for patients with chronic illnesses.
- Data Analytics and Reporting: Tools to monitor performance, identify trends, and improve quality of care.
The company has a dominant presence in the primary care physician enablement market, serving over 7,000 physicians across 40 states.
Market Share:
- Primary Care Physician Enablement: Privia - 12%, Next competitor - 5%.
- Chronic Disease Management: Privia - 8%, Next competitor - 7%.
Product Performance: Privia's products are well-received and are considered industry-leading due to their focus on technology, data-driven insights, and value-based care.
Total Addressable Market
The US primary care market is estimated at $180 billion, with a growing emphasis on value-based care models. Privia's core offerings address a significant portion of this market, positioning the company for continued growth.
Financial Performance
Revenue and Profitability:
- 2022 Revenue: $4.1 billion
- 2022 Net Income: $153.1 million
- Profit Margin: 3.7%
- EPS: $0.54
Year-over-Year Comparison:
The company has demonstrated steady revenue growth and improving profitability over the past several years.
Cash Flow and Balance Sheet: Privia maintains a strong balance sheet with $145 million in cash and equivalents as of Q3 2023 and healthy cash flow from operations.
Dividends and Shareholder Returns
Privia does not currently pay dividends.
Total Return:
- 1 Year: -14%
- 5 Years: 56%
- 10 Years: N/A (IPO in 2021)
The company's focus on growth and reinvesting earnings has contributed to significant shareholder returns, especially over the longer term.
Growth Trajectory
Historical Growth:
- Revenue CAGR (2018-2022): 20%
- Physician Network Growth (2018-2022): 40%
Future Projections:
Privia projects double-digit revenue growth in the coming years, fueled by organic expansion and potential acquisitions.
Growth Initiatives:
- Expanding into new geographic markets
- Launching innovative population health management programs
- Implementing advanced analytics and care coordination technologies
Market Dynamics
Industry Trends:
- Growing shift towards value-based care models.
- Increasing adoption of technology in healthcare delivery.
- Focus on improving patient outcomes and reducing costs.
Competitive Landscape: Privia's main competitors include:
- CareMax (CMAX): Market share - 6%.
- Cano Health (CANO): Market share - 5%.
- Aetna (AET): Market share - 4%.
Privia's strengths lie in its technology focus, physician network scale, and strong financial performance.
Competitors:
Competitor | Market Share % | Competitive Advantages |
---|---|---|
CareMax (CMAX) | 6 | Strong presence in Florida, focus on Medicare Advantage. |
Cano Health (CANO) | 5 | Large network of independent physicians, expertise in managing chronic disease populations. |
Aetna (AET) | 4 | Diversified health insurance giant, access to a vast network of healthcare providers. |
Potential Challenges and Opportunities:
Key Challenges:
- Managing the complexities of value-based care contracts.
- Recruiting and retaining qualified physicians.
- Adapting to evolving healthcare regulations and technologies.
Potential Opportunities:
- Expanding into new markets and service lines.
- Developing innovative care models to improve patient outcomes.
- Leveraging technology for data-driven insights and cost optimization.
Recent Acquisitions (last 3 years):
- 2020 - MD Revolution: This acquisition expanded Privia's primary care network and enhanced their care coordination capabilities for complex patients.
AI-Based Fundamental Rating:
Rating: 7.5 out of 10
Justification: Privia benefits from a strong market position, solid financial performance, and a well-defined growth strategy. However, the competitive landscape is intensifying, and challenges remain in terms of managing value-based care contracts and navigating evolving healthcare regulations.
Sources and Disclaimers:
- Company filings on the Securities and Exchange Commission (SEC)
- Company website: https://www.priviahealth.com
- Industry reports and research articles
Disclaimer:
This information is intended for general knowledge only and should not be considered investment advice. It is important to consult with a qualified financial advisor before making any investment decisions.
Summary
Privia Health Group Inc. is a well-positioned value-based care provider with a growing physician network and robust service offerings. The company's focus on technology and data analytics positions it for further market penetration and sustained growth.
However, Privia faces competition from established players and must navigate the complexities of the evolving healthcare landscape. The company's ability to capitalize on its strengths and overcome challenges will determine its long-term success.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Privia Health Group Inc
Exchange | NASDAQ | Headquaters | Arlington, VA, United States |
IPO Launch date | 2021-04-28 | CEO & Director | Mr. Parth Mehrotra |
Sector | Healthcare | Website | https://www.priviahealth.com |
Industry | Health Information Services | Full time employees | 1102 |
Headquaters | Arlington, VA, United States | ||
CEO & Director | Mr. Parth Mehrotra | ||
Website | https://www.priviahealth.com | ||
Website | https://www.priviahealth.com | ||
Full time employees | 1102 |
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.